BABYO2- colloidal silver and glycerin solution 
Oxigenesis, Inc.

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

BabyO2™

Active ingredients                                                          Purpose

Colloidal Silver 2 mg ................................................   Skin Protectant

Glycerin (Plant) 2 mg................................................   Skin Protectant

Uses

Relieves and prevents the discomfort and symptoms from: diaper rash, chaffed skin, minor burns and abrasions.

Warnings

For external use only.

Do not use over puncture wounds, infections or lacerations.

Avoid contact with the eyes.

Stop use and ask a doctor if condition worsens or does not improve in 7 days.

Keep out of reach of children.

Directions

Change wet and solid diapers promptly. Cleanse diaper area and dry. Apply ointment liberally as often necessary with every diaper change, especially at bedtime.

Other information

Sstore at 20°-25°C (68° -70° F)

Inactive ingredients

Distilled water, Sodium Chloride, Hydroxypropyl Starch Phosphate.

Marketed & Distributed by:

Oxigenesis, Inc.
2917 Union Road, Suite B
Paso Robles, CA 93446 USA
805-549-0275

BabyO2

BABYO2 
colloidal silver and glycerin solution
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:72136-005
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SILVER (UNII: 3M4G523W1G) (SILVER - UNII:3M4G523W1G) SILVER2 mg  in 240 mL
GLYCERIN (UNII: PDC6A3C0OX) (GLYCERIN - UNII:PDC6A3C0OX) GLYCERIN2 mg  in 240 mL
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
SODIUM CHLORIDE NA-22 (UNII: VMP9781061)  
HYDROXYPROPYL CORN STARCH (5% SUBSTITUTION BY WEIGHT) (UNII: 9M44R3409A)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:72136-005-01240 mL in 1 TUBE; Type 0: Not a Combination Product02/26/2019
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other02/26/2019
Labeler - Oxigenesis, Inc. (006774725)
Registrant - Oxigenesis, Inc. (006774725)
Establishment
NameAddressID/FEIBusiness Operations
Oxigenesis, Inc.006774725manufacture(72136-005)

Revised: 2/2019
Document Id: 9985b88d-2b8a-4b22-8282-3d69302aef84
Set id: 9ee0b8da-4f82-46e9-88ae-0f7710fd8d53
Version: 3
Effective Time: 20190226
 
Oxigenesis, Inc.